The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer

BJU International

Volumn 110, Issue 6, 2012, Pages 884-890

  Stewart, Grant D ^a   Ang, W Jensen ^a   Laird, Alexander ^a   Tolley, David A ^a   Riddick, Antony C P ^a   McNeill, S Alan ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

cytoreductive nephrectomy; laparoscopic radical nephrectomy; locally advanced; oncological outcome; operative safety; renal cell carcinoma

Indexed keywords

EVEROLIMUS; INTERFERON; SUNITINIB;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LAPAROSCOPIC NEPHRECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOTHERAPY; NEPHRECTOMY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SAFETY; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84865479646     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10850.x     Document Type: Article

References (24)

1. Ljungberg B, Cowan NC, Hanbury DC, et al,. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398-406
2. Burgess NA, Koo BC, Calvert RC, Hindmarsh A, Donaldson PJ, Rhodes M,. Randomized trial of laparoscopic v open nephrectomy. J Endourol 2007; 21: 610-3
3. Hemal AK, Kumar A, Kumar R, Wadhwa P, Seth A, Gupta NP,. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol 2007; 177: 862-6
4. Permpongkosol S, Chan DY, Link RE, et al,. Long-term survival analysis after laparoscopic radical nephrectomy. J Urol 2005; 174: 1222-5
5. Lawrentschuk N, Gani J, Riordan R, Esler S, Bolton DM,. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005; 96: 291-5
6. Martin GL, Castle EP, Martin AD, et al,. Outcomes of laparoscopic radical nephrectomy in the setting of vena caval and renal vein thrombus: seven-year experience. J Endourol 2008; 22: 1681-5
7. Guzzo TJ, Schaeffer EM, McNeil BK, Pollock RA, Pavlovich CP, Allaf ME,. Laparoscopic radical nephrectomy for patients with pathologic T3b renal-cell carcinoma: the Johns Hopkins experience. J Endourol 2009; 23: 63-7
8. Bensalah K, Salomon L, Lang H, et al,. Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy. BJU Int 2009; 104: 1714-7
9. Bird VG, Shields JM, Aziz M, Ayyathurai R, De Los Santos R, Roeter DH,. Laparoscopic radical nephrectomy for patients with T2 and T3 renal-cell carcinoma: evaluation of perioperative outcomes. J Endourol 2009; 23: 1527-33
10. Moch H, Artibani W, Delahunt B, et al,. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 2009; 56: 636-43
11. Clavien PA, Barkun J, de Oliveira ML, et al,. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96
12. Levy DA, Slaton JW, Swanson DA, Dinney CP,. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998; 159: 1163-7
13. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A,. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000; 163: 1090-5
14. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H,. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005; 173: 1889-92
15. Davenport K, Timoney AG, Keeley FX, Joyce A, Downey P,. A 3-year review of The British Association of Urological Surgeons Section of Endourology Laparoscopic Nephrectomy Audit. BJU Int 2006; 97: 333-7
16. Davenport K,. Laparoscopic Nephrectomy Audit July 2007-June 2008. 2008. Available at: http://www.baus.org.uk/Resources/BAUS/Documents/PDF%20Documents/ Sections/Endourology/lap-nephrectomy-audit08.pdf. Accessed April 2011
17. Zisman A, Pantuck AJ, Belldegrun AS, Schulam PG,. Laparoscopic radical nephrectomy. Semin Urol Oncol 2001; 19: 114-22
18. Taari K, Perttila I, Nisen H,. Laparoscopic versus open nephrectomy for renal cell carcinoma? Scand J Surg 2004; 93: 132-6
19. Ljungberg B, Alamdari FI, Rasmuson T, Roos G,. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999; 84: 405-11
20. Nozawa H, Tsuchiya M, Kobayashi T, et al,. Small intestinal metastasis from renal cell carcinoma exhibiting rare findings. Int J Clin Pract 2003; 57: 329-31
21. Nakatani K, Nakamoto Y, Saga T, Higashi T, Togashi K,. The potential clinical value of FDG-PET for recurrent renal cell carcinoma. Eur J Radiol 2009; 79: 29-35
22. Stewart GD, Tolley DA,. What are the oncological risks of minimal access surgery for the treatment of urinary tract cancer? Eur Urol 2004; 46: 415-20
23. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. Kidney. AJCC Cancer Staging Manual. Vol. 7. New York, NY: Springer, 2010: 479-89
24. Gore ME, Griffin CL, Hancock B, et al,. Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial. Lancet 2010; 375: 641-8